Abstract:The control of retroviral infection by antiviral factors referred to as restriction factors has become an exciting area in infectious disease research. TRIM5α has emerged as an important restriction factor impacting on retroviral replication including HIV-1 replication in primates. TRIM5α has a tripartite motif comprising RING, B-Box and coiled coil domains. The antiviral α splice variant additionally encodes a B30.2 domain which is recruited to incoming viral cores and determines antiviral specificity. TRIM5 is ubiquitinylated and rapidly turned over by the proteasome in a RING dependent way. Protecting restricted virus from degradation, by inhibiting the proteasome, rescues DNA synthesis, but not infectivity, indicating that restriction of infectivity by TRIM5α does not depend on the proteasome but the early block to DNA synthesis is likely to be mediated by rapid degradation of the restricted cores. The peptidyl prolyl isomerase enzyme cyclophilin A isomerises a peptide bond on the surface of the HIV-1 capsid and impacts on sensitivity to restriction by TRIM5α from Old World monkeys. This suggests that TRIM5α from Old World monkeys might have a preference for a particular capsid isomer and suggests a role for cyclophilin A in innate immunity in general. Whether there are more human antiviral TRIMs remains uncertain although the evidence for TRIM19's (PML) antiviral properties continues to grow. A TRIM5-like molecule with broad antiviral activity in cattle suggests that TRIM mediated innate immunity might be common in mammals. Certainly the continued study of restriction of viral infectivity by antiviral host factors will remain of interest to a broad audience and impact on a variety of areas including development of animal models for infection, development of viral vectors for gene therapy and the search for novel antiviral drug targets.

Tripartite motif proteins: an emerging antiviral protein family

Tripartite-motif proteins and innate immune regulation

The interplay between viruses and TRIM family proteins

Regulation of Tripartite Motif-Containing Proteins on Immune Response and Viral Evasion

Exploring TRIM proteins' role in antiviral defense against influenza A virus and respiratory coronaviruses

TRIM5α: A Protean Architect of Viral Recognition and Innate Immunity

The control of viral infection by tripartite motif proteins and cyclophilin A

Mechanistic Role of TRIM26 in Viral Infection and Host Defense

TRIM Proteins and Antiviral Microtubule Reorganization: A Novel Component in Innate Immune Responses?

To TRIM or not to TRIM: the balance of host-virus interactions mediated by the ubiquitin system

To TRIM the Immunity: From Innate to Adaptive Immunity

Multiple Roles of TRIM21 in Virus Infection

TRIM Proteins: Key Regulators of Immunity to Herpesvirus Infection

TRIM21—From Intracellular Immunity to Therapy

TRIM25 and its emerging RNA-binding roles in antiviral defense

Retroviral Restriction Factors Trim5 Alpha: Therapeutic Strategy To Inhibit Hiv-1 Replication

InTRIMsic immunity: Positive and negative regulation of immune signaling by tripartite motif proteins

Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function

Interplay between TRIM7 and antiviral immunity

TRIMming down Flavivirus Infections

Regulation of Mitochondria-Derived Immune Activation by 'Antiviral' TRIM Proteins